Preclinical and Clinical Evidence of Antioxidant Effects of Antidepressant Agents: Implications for the Pathophysiology of Major Depressive Disorder
Major depressive disorder (MDD) is a common mental disorder associated with a significant negative impact on quality of life, morbidity/mortality, and cognitive function. Individuals who suffer with MDD display lower serum/plasmatic total antioxidant potentials and reduced brain GSH levels. Also, F2...
Main Authors: | Guilherme A. Behr, José C. F. Moreira, Benicio N. Frey |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2012-01-01
|
Series: | Oxidative Medicine and Cellular Longevity |
Online Access: | http://dx.doi.org/10.1155/2012/609421 |
Similar Items
-
Pharmacogenomics of antidepressants response in major depressive disorder
by: Marlene Elisabete Moreira dos Santos Lima
Published: (2019) -
Title Clinical Evidence of Antidepressant Effects of Insulin and Anti-Hyperglycemic Agents and Implications for the Pathophysiology of Depression—A Literature Review
by: Young Sup Woo, et al.
Published: (2020-09-01) -
Effects of Antidepressants Therapy to Brain White Matter and Antioxidative Activity in Patients with Major Depressive Disorder
by: Chun-Te, et al.
Published: (2012) -
Major Depression Disorder in Adults: A Review of Antidepressants
Published: (2019-01-01) -
The Role of Chemokines in the Pathophysiology of Major Depressive Disorder
by: Vladimir M. Milenkovic, et al.
Published: (2019-05-01)